Biotechnology Assets

Logo Biotechnology Assets

Logo Biotechnology Assets

Contact information

Biotechnology Assets
Victor Infante, Vicepresidente Ejecutivo
Av. Desarrollo Tecnológico 11.
Jerez de la Frontera
Cádiz
856818424
Areas of activities
  • A. Health Biotechnology
    • Areas of activity
      • Biodrugs
      • In vitro diagnostics
      • Vaccines
    • Therapeutic areas
      • Genetic and rare diseases
      • Infectious diseases
      • Immunology
  • B. Agrifood Biotechnology
    • Agriculture / veterinary / environmental
      • Animal health / Veterinary
  • D. Services
    • Professional services
  • CRO / CMO / SMO

Biat Group is a biotechnology corporate group formed by various subsidiaries and a global commercial structure. 

Under the corporate umbrella of the group holding (Bionatur) a global business and commercial network to promote Biobide, ZIP Solutions, and Bionatur assets.

Products and services

1) Biobide (Donosti and Boston) is a worldwide leader in the zebrafish (ZF) animal model offering tailor-made toxicity and efficacy testing. ZF gathers together all in one the best features of in-vitro and in-vivo testing.

2) ZIP Solutions (Barcelona) promotes its unique proprietary set of inteins in many high value industrial applications: Click-gene for gene therapy; Click-bio for immunotherapy; Click-Dx for IVD; Click-VLP for smart vaccines; Vacc-Zera for RNA & DNA vaccines; and Click-DSP for affinity-based protein purification.

3) Bionatur (Jerez de la Frontera). Biotech unique assets for human and animal health.

Areas of interest for future collaborations

Licensing of biotech platforms and products; Toxicity and efficacy preclinical research; Improvement of recombinant and DNA vaccines

Biotech Sanitaria

Research Platforms
Product / Service Type Development phase
CLICK´N CUT Other Preclinical
CLICK-VLP Drug Delivery, Enabling Technologies Clinical Validation
CLICK-CAR Drug Delivery, Enabling Technologies Preclinical
VACC-ZERA paltform Drug Delivery, Enabling Technologies Clinical Validation
CLICK-GENE CRO, CMO, Enabling Technologies Preclinical
CLICK-TARGET CRO, CMO, Drug Delivery, Enabling Technologies Preclinical

Biotech Agroalimentaria

Veterinary Drugs
Product / Service Therapeutic area Development phase
BNT025 (MUPIPET) Enfermedades infecciosas P II

Biotech Industrial

Bioprocess
Product / Service Development phase
Fermentation-based ingredients Ready for explotation